Clinical Trial Update: Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cabozantinib in combination with atezolizumab for muscle-invasive bladder cancer; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Deepak Kilari | Conditions: Bladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING